All Pharma articles – Page 23
-
NewsReturned drug money should not fund waiting list drive
The billions of pounds due to be clawed back from pharma firms under a new NHS pricing deal should not be diverted to help hospitals cut waiting lists, the head of the Association of British Pharmaceutical Industry has urged.
-
CommentIs big retail the therapy for NHS care?
Retailers expanding into primary care could work in the NHS
-
LeaderWeak spending pledges mean more rationing and tighter control
The debate about NHS finances is changing
-
NewsExclusive: NHS England could curb access to NICE approved drug
Patients could be denied access to a groundbreaking drug that cures Hepatitis C because the NHS cannot afford it, HSJ has learned.
-
SupplementsPatient experience special report: Quality care begins at home
Home monitoring can improve life for patients
-
HSJ KnowledgeReduce antipsychotic prescriptions to save dementia patients
GPs and pharmacists work together
-
SupplementsUnblock the system: how to treat DVT in the community
Innovative new treatments are saving NHS money
-
SupplementsSpecial report: The sticking point for medication adherence
Understanding patients’ reasons why
-
CommentCancer drug announcements must be backed up with action
There’s an element of pre-election tidying
-
News£160m boost for cancer drugs fund
Thousands more cancer patients in England will be offered vital treatments in a £160m boost to the cancer drugs fund, the Department of Health has said.
-
CommentMedicalising common ailments is one of healthcare's greatest threats
It stops long term changes
-
NewsGPs feel pressured over antibiotics
Almost half of GPs have admitted prescribing antibiotics even though they know they will not treat the patient’s condition, a survey shows.
-
NewsDiabetes prescriptions soar to 45m
The number of drugs issued to treat diabetes has soared, new figures show.
-
NewsNICE on the offensive in row over breast cancer drug
NICE has taken the unprecedented step of expressing its ‘disappointment’ with a multinational drug giant in a row over a new breast cancer drug and the government’s pricing deal
-
CommentNICE must reduce the red tape to make cancer drug access a reality
It shows up entrenched conservativism
-
HSJ KnowledgeOnly a whole culture change can make self-care a reality
There is no magic wand to care redesign
-
NewsUK to lead superbug fight - Cameron
Britain will lead the fightback against antibiotic-resistant superbugs threatening to send medicine “back into the dark ages”, David Cameron has said.
-
SupplementsClinical leaders: Pharma on the front line
Pharmacists are well placed to take a central role in the care of patients with chronic conditions
-
NewsInfection fears after baby death
Health officials cannot rule out that other babies might have been infected by the nutritional food product which has been “strongly linked” to the death of one baby and the illness of 14 others.
-
NewsExclusive: Whitehall big hitter joins DH to lead on pharma and IT
Will Cavendish, who currently oversees policy implementation across government for the Prime Minister, is to join the Department of Health in a new director general post with responsibility for pharma, IT and life sciences.